Organizations Filed Purposes:
AABB IS THE GLOBAL LEADER IN STANDARDS DEVELOPMENT, ACCREDITATION AND IMPLEMENTATION OF QUALITY SYSTEMS IN TRANSFUSION MEDICINE AND CELLULAR THERAPIES. AABB HAS AN UNWAVERING FOCUS ON DONOR AND PATIENT SAFETY. WE ACCOMPLISH THIS BY TRANSLATING KNOWLEDGE INTO SOLUTIONS THAT SHAPE THE FIELD OF TRANSFUSION MEDICINE AND CELLULAR THERAPIES. AABB BRINGS TOGETHER THOSE ENGAGED IN TRANSFUSION MEDICINE AND CELLULAR THERAPIES. AABB CREATES A UNIQUE LEARNING ENVIRONMENT, INCLUDING OUR SIGNATURE ANNUAL MEETING, THAT INSPIRES AND ENABLES RESEARCH, INNOVATION, DISCOVERY AND EXCELLENCE.
A CONNECTED COMMUNITY DEDICATED TO ADVANCING TRANSFUSION MEDICINE AND BIOTHERAPIES. FROM DONOR TO PATIENT. FROM LAB TO BEDSIDE.
ACCREDITATION & EDUCATION:AABB DEVELOPS STANDARDS AND GUIDANCE FOR VOLUNTARY COMPLIANCE AND ACCREDITATION PROCESSES. THESE DEFINE OPTIMAL PATIENT AND DONOR CARE IN TRANSFUSION MEDICINE AND CELLULAR THERAPIES.
CONFERENCES & MEETINGS:AABB PROVIDES EDUCATIONAL PROGRAMS INCLUDING CONFERENCES AND AUDIO CONFERENCES TO PROVIDE CONTINUING PROFESSIONAL EDUCATION TO INDIVIDUALS IN THE FIELD OF TRANSFUSION MEDICINE AND CELLULAR AND RELATED BIOLOGICAL THERAPIES.
COMMUNICATIONS AND ONLINE PUBLICATIONS:AABB IS THE PREMIER PUBLISHER FOR PUBLICATIONS IN THE BLOOD BANKING, CELLULAR THERAPIES AND TRANSFUSION MEDICINE FIELD. OUR HIGH QUALITY PUBLICATIONS AND PRACTICE STANDARDS ARE RELEVANT FOR TODAY'S HEALTHCARE PROFESSIONALS. AABB ADVANCES THE ACQUISITION, TRANSLATION, AND APPLICATION OF NEW KNOWLEDGE IN THE DISCIPLINES OF BASIC, CLINICAL, BEHAVIORAL, MANAGERIAL AND LABORATORY SCIENCES AS THEY APPLY TO TRANSFUSION MEDICINE, CELLULAR AND RELATED BIOLOGICAL THERAPIES THROUGH ITS SCHOLARLY JOURNAL, "TRANSFUSION". IN ADDITION, AABB INFORMS ITS MEMBERS THROUGH DAILY, WEEKLY, AND MONTHLY NEWSLETTERS, BULLETINS, MAGAZINES AND ONLINE PEER TO PEER INTEGRATION THROUGH THE AABB HUB.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Debra Benavram | CEO | 35.5 | $449,285 |
| Eduardo Nunes | VP SCIENCE AND PRACTICE | 37.5 | $200,415 |
| Julia L Zimmerman | VP ENGAGEMENT | 37.5 | $187,092 |
| Christine Bales | VP GLOBAL AND CONSULTING | 37.5 | $176,552 |
| Diane Killion | GENERAL COUNSEL | 37.5 | $164,136 |
| Margaret M Boraz | VP PUBLIC POLICY & ADVOCACY | 37.5 | $154,778 |
| Kathleen Loper | SR. DIR CTR FOR CELLULAR THERAPIES | 37.5 | $153,778 |
| Jeffrey Winters | REPRESENTATIVE (THRU 10/19) | 2 | $0 |
| Aaron Tobian | AT LARGE DIRECTOR (THRU 10/19 | 2 | $0 |
| Steven Spitalnik | AT LARGE DIRECTOR (THRU 10/19 | 2 | $0 |
| Celina Montemayor | APPOINTED DIRECTOR (THRU 10/19) | 2 | $0 |
| Melanie Champion | AT LARGE DIRECTOR (THRU 10/19 | 2 | $0 |
| P Dayand Borge Jr | AT LARGE DIRECTOR (THRU 10/19 | 2 | $0 |
| Richard Schafer | AT LARGE DIRECTOR | 2 | $0 |
| Deborah Sesok-Pizzini | AT LARGE DIRECTOR | 2 | $0 |
| Debra Kessler | AT LARGE DIRECTOR | 2 | $0 |
| Jerry Holmberg | AT LARGE DIRECTOR (AS OF 10/19) | 2 | $0 |
| Colleen Delaney | AT LARGE DIRECTOR (AS OF 10/19) | 2 | $0 |
| Tony Casina | AT LARGE DIRECTOR | 2 | $0 |
| Jose Cancelas | AT LARGE DIRECTOR (AS OF 10/19) | 2 | $0 |
| Barbara Bryant | AT LARGE DIRECTOR | 2 | $0 |
| Julie Allickson | AT LARGE DIRECTOR | 2 | $0 |
| Michael Murphy | PAST PRESIDENT (AS OF 10/19) | 4 | $0 |
| Brian Gannon | TREASURER | 4 | $0 |
| Steven Sloan | SECRETARY (AS OF 10/19) | 4 | $0 |
| Dana Devine | VICE PRESIDENT (AS OF 10/19) | 4 | $0 |
| David Green | PRESIDENT ELECT (AS OF 10/19) | 4 | $0 |
| Beth Shaz | PRESIDENT (AS OF 10/19) | 4 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202033219349316043_public.xml